Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
78
datasets available to search
ShareScore release 0.9.0
Dataset results
78 results for “HCC recurrence”
Impact of Graft Reconditioning With Hypothermic Machine Perfusion on HCC Recurrence After Liver Transplantation
ClinicalTrials.gov study NCT06236568. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Neoadjuvant HAIC and PD-1 Plus Adjuvant PD-1 for High-risk Recurrent HCC
ClinicalTrials.gov study NCT06467799. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sintilimab Plus Bevacizumab as Adjuvant Therapy in HCC Patients at High Risk of Recurrence After Curative Resection
ClinicalTrials.gov study NCT04682210. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
AI-Based Prediction of HCC Recurrence Patterns After Resection (APAR)
ClinicalTrials.gov study NCT07062380. IPD Sharing: NO. Countries: 1. Publications: 0.
Magnetic Resonance Elastography (MRE) as a Predictor of HCC Recurrence After Radiofrequency Ablation (RFA)
ClinicalTrials.gov study NCT01447667. IPD Sharing: NO. Countries: 1. Publications: 0.
Cell-free DNA From Junction of Hepatitis B Virus Integration in HCC Patients for Monitoring Post-resection Recurrence
ClinicalTrials.gov study NCT05823584. IPD Sharing: NO. Countries: 1. Publications: 0.
Expanded Activated Lymphocytes (EAL) as Adjuvant Therapy in Patients With HCC at High Risk of Recurrence After Radical Resection
ClinicalTrials.gov study NCT05213637. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bevacizumab Biosimilar Plus FOLFOX4 in the Treatment of Recurrent HCC After Liver Transplantation
ClinicalTrials.gov study NCT05355155. IPD Sharing: NO. Countries: 1. Publications: 0.
Heterogeneity and Evolution of hepatoceLlular Carcinoma in Post-transplant HCC Recurrence
ClinicalTrials.gov study NCT04506398. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Stereotactic Body Radiation Therapy for the Safety and Prognosis of Small Intrahepatic Recurrent HCC
ClinicalTrials.gov study NCT05596630. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate TACE Sequential Tislelizumab as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection
ClinicalTrials.gov study NCT04981665. IPD Sharing: NO. Countries: 1. Publications: 0.
HAIC Combined With Anlotinib and TQB2450 as Adjuvant Therapy in HCC Patients With High Risk of Recurrence After Resection
ClinicalTrials.gov study NCT05311319. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combi-elastography Assessment of HCC Recurrence After Thermal Ablation Multi-center Study
ClinicalTrials.gov study NCT04640363. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-recurrence Treatment of Postresection on HCC Patients With MVI Presence and Over-expression of ASPH
ClinicalTrials.gov study NCT02587884. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment
ClinicalTrials.gov study NCT03847428. IPD Sharing: YES. Countries: 24. Publications: 0.
Sorafenib Combined With Arsenical in Treating Patients With Recurrent HCC After Liver Transplantation
ClinicalTrials.gov study NCT04232722. IPD Sharing: NO. Countries: 1. Publications: 0.
Impact of Hepatectomy on HCC Recurrence
ClinicalTrials.gov study NCT06390228. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Adjuvant Anti-Recurrence Treatment With Rapamycin on Early-stage HCC
ClinicalTrials.gov study NCT02724332. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Novel Immunotherapy PD-1 Antiboty to Suppress Recurrence of HCC Combined With PVTT After Hepatic Resection
ClinicalTrials.gov study NCT03914352. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate Tislelizumab Combined With Sitravatinib as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection
ClinicalTrials.gov study NCT05407519. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.